Literature DB >> 11562619

Neuropsychologic performance in school-aged children with sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease.

W Wang1, L Enos, D Gallagher, R Thompson, L Guarini, E Vichinsky, E Wright, R Zimmerman, F D Armstrong.   

Abstract

OBJECTIVES: To compare the results of serial neuropsychologic testing in children with sickle cell disease with the results of serial magnetic resonance imaging (MRI) examinations, particularly to evaluate neuropsychologic function in the absence of overt stroke. STUDY
DESIGN: In the Cooperative Study of Sickle Cell Disease, serial neuropsychologic and MRI tests were performed in 373 patients (255 with hemoglobin SS and 118 with hemoglobin SC), 6 to 18 years of age. MRI of the brain and a neuropsychologic battery that included the Wechsler Intelligence Scale for Children (WISC-R or WISC-III) and the Woodcock-Johnson Math and Reading Achievement Tests were performed concurrently and repeated every 2 to 3 years. A silent infarct was defined as an MRI finding of increased signal intensity on T(2) imaging in a patient without a history of stroke.
RESULTS: Twenty-seven patients, all with hemoglobin SS, had overt strokes and 62 had silent infarcts (52 with hemoglobin SS). Patients with hemoglobin SS and silent infarcts had significantly lower scores for math and reading achievement, Full-Scale IQ, Verbal IQ, and Performance IQ, when compared with those with normal MRI findings. In children with hemoglobin SS and normal MRI findings, the scores for Verbal IQ, math achievement, and coding (a subscale of Performance IQ) declined with increasing age.
CONCLUSIONS: School-aged children with sickle cell disease had compromised neuropsychologic function in the presence of silent infarcts. In addition, they had declines in performance in certain areas of function over time. Therapeutic interventions that prevent or lessen cognitive impairment are needed before school entry for children with sickle cell disease.

Entities:  

Mesh:

Year:  2001        PMID: 11562619     DOI: 10.1067/mpd.2001.116935

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  71 in total

1.  Discontinuing prophylactic transfusions increases the risk of silent brain infarction in children with sickle cell disease: data from STOP II.

Authors:  Miguel R Abboud; Eunsil Yim; Khaled M Musallam; Robert J Adams
Journal:  Blood       Date:  2011-06-01       Impact factor: 22.113

Review 2.  The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease.

Authors:  John J Strouse; Sophie Lanzkron; Victor Urrutia
Journal:  Expert Rev Hematol       Date:  2011-12       Impact factor: 2.929

Review 3.  Imaging in childhood arterial ischaemic stroke.

Authors:  Brynmor P Jones; Vijya Ganesan; Dawn E Saunders; W Kling Chong
Journal:  Neuroradiology       Date:  2010-05-06       Impact factor: 2.804

4.  Cognitive functioning in children from Nigeria with sickle cell anemia.

Authors:  Olubusola B Oluwole; Robert B Noll; Daniel G Winger; Olu Akinyanju; Enrico M Novelli
Journal:  Pediatr Blood Cancer       Date:  2016-07-09       Impact factor: 3.167

5.  White matter damage in asymptomatic patients with sickle cell anemia: screening with diffusion tensor imaging.

Authors:  B Sun; R C Brown; L Hayes; T G Burns; J Huamani; D J Bearden; R A Jones
Journal:  AJNR Am J Neuroradiol       Date:  2012-05-17       Impact factor: 3.825

6.  Sickle cell anemia and academic achievement in Africa.

Authors:  Ayokunle T Abegunde
Journal:  J Natl Med Assoc       Date:  2005-10       Impact factor: 1.798

7.  Differences in Activation and Deactivation in Children with Sickle Cell Disease Compared with Demographically Matched Controls.

Authors:  B Sun; R C Brown; T G Burns; D Murdaugh; S Palasis; R A Jones
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-13       Impact factor: 3.825

8.  Inverse correlation between cerebral blood flow measured by continuous arterial spin-labeling (CASL) MRI and neurocognitive function in children with sickle cell anemia (SCA).

Authors:  John J Strouse; Christiane S Cox; Elias R Melhem; Hanzhang Lu; Michael A Kraut; Alexander Razumovsky; Kaleb Yohay; Peter C van Zijl; James F Casella
Journal:  Blood       Date:  2006-03-14       Impact factor: 22.113

9.  Supporting family adaptation to presymptomatic and "untreatable" conditions in an era of expanded newborn screening.

Authors:  Donald B Bailey; F Daniel Armstrong; Alex R Kemper; Debra Skinner; Steven F Warren
Journal:  J Pediatr Psychol       Date:  2008-03-30

10.  Working Memory in Children With Neurocognitive Effects From Sickle Cell Disease: Contributions of the Central Executive and Processing Speed.

Authors:  Kelsey E Smith; Jeffrey Schatz
Journal:  Dev Neuropsychol       Date:  2016-10-19       Impact factor: 2.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.